ATG7 and neoplasm: Studies in GEM models of Braf-mutated lung cancer indicated that expression of BRAFV600E in conjunction with autophagy inhibition through genetic silencing of Atg7 enhances the development of early-stage lung tumors, suggesting a tumor-suppressive role of autophagy at least at early stages in lung tumorigenesis [83].